In conclusion, retrospective cohort studies suggest that BRCA1/2-mutated ovarian cancers often present with a substantial disease burden at diagnosis; however, peritoneal lesions tend to exhibit less infiltrative architecture, potentially facilitating easier surgical excision. Here, BRCA1 is linked to ovarian carcinoma.